Neumora’s Depression Treatment Fails First Phase 3 Trial
Neumora Therapeutics CEO Henry Gosebruch announced that the company’s experimental major depression treatment failed its first Phase 3 clinical trial. The results marked a setback for the neuroscience drug developer, which had high hopes for its therapy. This is not the first time Neumora has faced challenges in its pipeline; previous trials have also shown … Read more